Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B Leyden.

Kurachi S, Huo JS, Ameri A, Zhang K, Yoshizawa AC, Kurachi K.

Proc Natl Acad Sci U S A. 2009 May 12;106(19):7921-6. doi: 10.1073/pnas.0902191106.

2.

AAV-mediated gene transfer for hemophilia.

High KA.

Ann N Y Acad Sci. 2001 Dec;953:64-74. Review.

PMID:
11795424
3.

Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.

High KA.

Trans Am Clin Climatol Assoc. 2003;114:337-51; discussion 351-2. Review.

4.

Gene therapy for hemophilia.

Lynch CM.

Curr Opin Mol Ther. 1999 Aug;1(4):493-9. Review.

PMID:
11713765
5.

Gene therapy for the hemophilias.

VandenDriessche T, Collen D, Chuah MK.

J Thromb Haemost. 2003 Jul;1(7):1550-8. Review.

6.

Hemophilia B Leyden and once mysterious cis-regulatory mutations.

Funnell AP, Crossley M.

Trends Genet. 2014 Jan;30(1):18-23. doi: 10.1016/j.tig.2013.09.007. Review.

PMID:
24138812
7.

Progress towards gene therapy for the hemophilias.

Thompson AR.

Thromb Haemost. 1995 Jul;74(1):45-51. Review.

PMID:
8578505
8.

Gene therapy strategies for hemophilia: benefits versus risks.

Petrus I, Chuah M, VandenDriessche T.

J Gene Med. 2010 Oct;12(10):797-809. doi: 10.1002/jgm.1500. Review.

PMID:
20848668
9.

Viral vector-mediated gene therapy for hemophilia.

VandenDriessche T, Collen D, Chuah MK.

Curr Gene Ther. 2001 Sep;1(3):301-15. Review.

PMID:
12109144
10.

Deficiencies in factors IX and VIII: what is now known.

Kurachi K, Yao SN, Furukawa M, Kurachi S.

Hosp Pract (Off Ed). 1992 Feb 15;27(2):41-51. Review.

PMID:
1735764
11.

Gene transfer as an approach to treating hemophilia.

High KA.

Circ Res. 2001 Feb 2;88(2):137-44. Review.

12.

Problems and prospects in gene therapy for hemophilia.

Herzog RW, High KA.

Curr Opin Hematol. 1998 Sep;5(5):321-6. Review.

PMID:
9776210
13.

Gene therapy of the hemophilias.

Lozier J.

Semin Hematol. 2004 Oct;41(4):287-96. Review.

PMID:
15508114
14.

Genetic mechanisms of age regulation of blood coagulation: factor IX model.

Kurachi K, Kurachi S.

Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):902-6. Review.

15.

Gene transfer as an approach to cure patients with hemophilia A or B.

Thompson AR, Palmer TD, Lynch CM, Miller AD.

Curr Stud Hematol Blood Transfus. 1991;(58):59-62. Review. No abstract available.

PMID:
1954775
16.

Status of gene transfer for hemophilia A and B.

Thompson AR.

Thromb Haemost. 1991 Jul 12;66(1):119-22. Review. No abstract available.

PMID:
1926041
17.

AAV-mediated gene therapy for hemophilia.

Couto LB, Pierce GF.

Curr Opin Mol Ther. 2003 Oct;5(5):517-23. Review.

PMID:
14601521
18.

Gene therapy for haemophilia.

Pasi KJ.

Baillieres Clin Haematol. 1996 Jun;9(2):305-17. Review. No abstract available.

PMID:
8800507
19.

Defining severity of hemophilia: more than factor levels.

Pavlova A, Oldenburg J.

Semin Thromb Hemost. 2013 Oct;39(7):702-10. doi: 10.1055/s-0033-1354426. Review.

PMID:
24026911
20.
Items per page

Supplemental Content

Support Center